IRIS Accounts Production v24.3.2.46 13345505 director 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh133455052023-04-30133455052024-04-30133455052023-05-012024-04-30133455052022-04-30133455052022-05-012023-04-30133455052023-04-3013345505ns15:EnglandWales2023-05-012024-04-3013345505ns14:PoundSterling2023-05-012024-04-3013345505ns10:Director12023-05-012024-04-3013345505ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3013345505ns10:SmallEntities2023-05-012024-04-3013345505ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3013345505ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3013345505ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3013345505ns10:FullAccounts2023-05-012024-04-3013345505ns10:RegisteredOffice2023-05-012024-04-3013345505ns5:CurrentFinancialInstruments2024-04-3013345505ns5:CurrentFinancialInstruments2023-04-3013345505ns5:Non-currentFinancialInstruments2024-04-3013345505ns5:Non-currentFinancialInstruments2023-04-3013345505ns5:ShareCapital2024-04-3013345505ns5:ShareCapital2023-04-3013345505ns5:RetainedEarningsAccumulatedLosses2024-04-3013345505ns5:RetainedEarningsAccumulatedLosses2023-04-3013345505ns5:FurnitureFittings2023-05-012024-04-3013345505ns5:MotorVehicles2023-05-012024-04-3013345505ns5:ComputerEquipment2023-05-012024-04-3013345505ns5:PlantMachinery2023-04-3013345505ns5:FurnitureFittings2023-04-3013345505ns5:MotorVehicles2023-04-3013345505ns5:ComputerEquipment2023-04-3013345505ns5:PlantMachinery2023-05-012024-04-3013345505ns5:PlantMachinery2024-04-3013345505ns5:FurnitureFittings2024-04-3013345505ns5:MotorVehicles2024-04-3013345505ns5:ComputerEquipment2024-04-3013345505ns5:PlantMachinery2023-04-3013345505ns5:FurnitureFittings2023-04-3013345505ns5:MotorVehicles2023-04-3013345505ns5:ComputerEquipment2023-04-3013345505ns5:CostValuation2023-04-3013345505ns5:RevaluationsIncreaseDecreaseInInvestments2024-04-3013345505ns5:CostValuation2024-04-3013345505ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3013345505ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 13345505 (England and Wales)









ROADIE MEDIC LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024






ROADIE MEDIC LIMITED (REGISTERED NUMBER: 13345505)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ROADIE MEDIC LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTOR: Dr S Arun-Castro





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 13345505 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

ROADIE MEDIC LIMITED (REGISTERED NUMBER: 13345505)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 26,469 32,859
Investments 5 5,000 5,005
31,469 37,864

CURRENT ASSETS
Debtors 6 826 301
Cash at bank 3,034 17,472
3,860 17,773
CREDITORS
Amounts falling due within one year 7 21,933 25,720
NET CURRENT LIABILITIES (18,073 ) (7,947 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

13,396

29,917

CREDITORS
Amounts falling due after more than one
year

8

19,056

20,722
NET (LIABILITIES)/ASSETS (5,660 ) 9,195

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings (5,662 ) 9,193
SHAREHOLDERS' FUNDS (5,660 ) 9,195

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ROADIE MEDIC LIMITED (REGISTERED NUMBER: 13345505)

BALANCE SHEET - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 January 2025 and were signed by:





Dr S Arun-Castro - Director


ROADIE MEDIC LIMITED (REGISTERED NUMBER: 13345505)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Roadie Medic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


ROADIE MEDIC LIMITED (REGISTERED NUMBER: 13345505)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 May 2023 - 1,689 42,000 1,543 45,232
Additions 2,574 - - 738 3,312
At 30 April 2024 2,574 1,689 42,000 2,281 48,544
DEPRECIATION
At 1 May 2023 - 844 10,500 1,029 12,373
Charge for year 644 423 7,875 760 9,702
At 30 April 2024 644 1,267 18,375 1,789 22,075
NET BOOK VALUE
At 30 April 2024 1,930 422 23,625 492 26,469
At 30 April 2023 - 845 31,500 514 32,859

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 May 2023 5,005
Revaluations (5 )
At 30 April 2024 5,000
NET BOOK VALUE
At 30 April 2024 5,000
At 30 April 2023 5,005

ROADIE MEDIC LIMITED (REGISTERED NUMBER: 13345505)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

5. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 30 April 2024 is represented by:

Other
investments
£   
Valuation in 2024 5,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors - 255
Other debtors 826 46
826 301

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security - 1,794
Other creditors 21,933 23,926
21,933 25,720

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Other creditors 19,056 20,722